United Therapeutics Short Interest Ratio and Short Volume

Short interest is the volume of United Therapeutics shares that have been sold short but have not yet been covered or closed out. As of August 31st, investors have sold 3,240,000 shares of UTHR short. 7.38% of United Therapeutics' shares are currently sold short. Learn More on United Therapeutics' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. United Therapeutics currently has a short interest ratio of 10.0. Learn More on a good short interest ratio for United Therapeutics

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of United Therapeutics: Walleye Trading LLC, Citadel Advisors LLC, SG3 Management LLC, Goldman Sachs Group Inc., Simplex Trading LLC, Susquehanna International Group LLP, and Wolverine Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 7.38% of United Therapeutics' floating shares are currently sold short.

United Therapeutics saw a increase in short interest in August. As of August 31st, there was short interest totaling 3,240,000 shares, an increase of 68.8% from the previous total of 1,920,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

United Therapeutics currently has issued a total of 44,923,000 shares. Some of United Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. United Therapeutics currently has a public float of 43,890,000 shares.

7.38% of United Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sub-industry of "biotechnology" compare to United Therapeutics: Amgen Inc. (1.98%), Gilead Sciences, Inc. (0.00%), Regeneron Pharmaceuticals, Inc. (1.33%), Vertex Pharmaceuticals Incorporated (1.87%), Biogen Inc. (1.60%), Seagen Inc. (1.45%), Alnylam Pharmaceuticals, Inc. (0.00%), Exact Sciences Co. (0.00%), Novavax, Inc. (8.25%), and Repligen Co. (3.08%).

As of the most recent reporting period, the following stocks had the largest short interest positions: Square, Inc. ($9.81 billion), S&P Global Inc. ($7.52 billion), Advanced Micro Devices, Inc. ($7.18 billion), Charter Communications, Inc. ($6.21 billion), Wayfair Inc. ($4.60 billion), Zoom Video Communications, Inc. ($3.23 billion), Uber Technologies, Inc. ($3.11 billion), Palo Alto Networks, Inc. ($2.74 billion), Teladoc Health, Inc. ($2.52 billion), and Etsy, Inc. ($2.16 billion). View all of the most shorted stocks.

Short selling UTHR is an investing strategy that aims to generate trading profit from United Therapeutics as its price is falling. United Therapeutics' stock is trading down $5.06 today. To short United Therapeutics stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that United Therapeutics will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for United Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of UTHR, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including UTHR, twice per month. The most recent reporting period available is August, 31 2021.